Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth
- PMID: 16941672
- DOI: 10.1002/pros.20476
Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth
Abstract
Background: Angiogenic and angiostatic CXC chemokines mediate their effects via the receptors, CXCR2 and CXCR3, respectively. The current study sought to determine whether the presence of these receptors alters prostate tumor growth.
Methods: Endothelial cell chemotaxis of prostate cell-derived products was determined in vitro. Transgenic adenocarcinoma of the mouse prostate (TRAMP) mice was bred with CXCR2- or CXCR3-knockout mice to determine the effects of these genes on prostate tumor growth.
Results: Normal prostate epithelial cells release CXCR3 ligands that limit endothelial cell chemotaxis. Prostate cancer cells release CXCR2 ligands that stimulated endothelial cell chemotaxis. Tumors in TRAMP/CXCR2(-/-) mice were significantly smaller than those in TRAMP/CXCR2(+/+) mice and had reduced angiogenesis. In contrast, tumors in TRAMP/CXCR3(-/-) mice were palpable much earlier than TRAMP/CXCR3(+/+) mice and had greatly increased angiogenesis.
Conclusions: The data suggest that signaling through CXCR2 and CXCR3 represents important counter-regulatory mechanisms that control the growth of prostate tumors.
Similar articles
-
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.Cancer Res. 2006 Apr 15;66(8):4198-207. doi: 10.1158/0008-5472.CAN-05-3842. Cancer Res. 2006. PMID: 16618742
-
Chemokine receptor CXCR3: an unexpected enigma.Curr Top Dev Biol. 2005;68:149-81. doi: 10.1016/S0070-2153(05)68006-4. Curr Top Dev Biol. 2005. PMID: 16124999 Review.
-
Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.Cancer Res. 2004 Sep 1;64(17):6137-43. doi: 10.1158/0008-5472.CAN-04-1287. Cancer Res. 2004. PMID: 15342397
-
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1130-7. doi: 10.1161/01.ATV.0000129537.72553.73. Epub 2004 Apr 22. Arterioscler Thromb Vasc Biol. 2004. PMID: 15105284
-
CXC chemokines in vascular remodeling related to pulmonary fibrosis.Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S67-9. Am J Respir Cell Mol Biol. 2003. PMID: 14503558 Review. No abstract available.
Cited by
-
Therapeutic inhibition of CXCR1/2: where do we stand?Intern Emerg Med. 2023 Sep;18(6):1647-1664. doi: 10.1007/s11739-023-03309-5. Epub 2023 May 30. Intern Emerg Med. 2023. PMID: 37249756 Free PMC article. Review.
-
High-Fat Diet-Induced Obese Effects of Adipocyte-Specific CXCR2 Conditional Knockout in the Peritoneal Tumor Microenvironment of Ovarian Cancer.Cancers (Basel). 2021 Oct 8;13(19):5033. doi: 10.3390/cancers13195033. Cancers (Basel). 2021. PMID: 34638514 Free PMC article.
-
CXCL3 Signaling in the Tumor Microenvironment.Adv Exp Med Biol. 2021;1302:15-24. doi: 10.1007/978-3-030-62658-7_2. Adv Exp Med Biol. 2021. PMID: 34286438 Review.
-
Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer.Cancers (Basel). 2021 May 25;13(11):2584. doi: 10.3390/cancers13112584. Cancers (Basel). 2021. PMID: 34070438 Free PMC article.
-
Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.Mol Cancer. 2021 Apr 4;20(1):62. doi: 10.1186/s12943-021-01355-1. Mol Cancer. 2021. PMID: 33814009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
